Abstract: Methods of detecting A? oligomers, such as may be present in a biological sample are described. The methods include detection using flow cytometry, detection using synthetic A? oligomers and/or in vitro methods detecting A? oligomers associated with cells.
Type:
Grant
Filed:
September 4, 2015
Date of Patent:
November 27, 2018
Assignee:
SYSTEM OF SYSTEMS ANALYTICS, INC.
Inventors:
Richard O. Cliff, Robert W. Flower, Evgenia G. Matveeva
Abstract: Described are methods for the detection, in the eye of an individual, of protein aggregates or other misfolded proteins associated with disease using peptide or peptide mimic probes that preferentially associate with the protein aggregates or misfolded proteins, which can be accomplished non-invasively.
Abstract: Described are methods for the detection, in the eye of an individual, of protein aggregates or other misfolded proteins associated with disease using peptide or peptide mimic probes that preferentially associate with the protein aggregates or misfolded proteins, which can be accomplished non-invasively.
Abstract: Disclosed are novel peptides that are useful, for example, for detecting target proteins having a ?-sheet secondary structure which may be associated with a disease, and for diagnosing and treating such a disease. Related methods and kits also are disclosed.
Type:
Grant
Filed:
June 9, 2014
Date of Patent:
July 4, 2017
Assignee:
SYSTEM OF SYSTEMS ANALYTICS, INC.
Inventors:
D. Roxanne Duan, Jonathan R. Moll, Alan Rudolph, Renee Wegrzyn
Abstract: The invention provides methods and kits for detecting conformationally altered proteins and prions in a sample. In one embodiment, the conformationally altered proteins and prions are associated with amyloidogenic diseases.
Type:
Grant
Filed:
September 12, 2014
Date of Patent:
May 2, 2017
Assignee:
SYSTEM OF SYSTEMS ANALYTICS, INC.
Inventors:
Cindy Orser, Anne Grosset, Eugene A. Davidson
Abstract: The present invention pertains to stabilized A? oligomer compositions. Methods for generating stabilized A? oligomer compounds are also provided herein. Additionally, screening assays employing the A? oligomer compounds and methods for generating therapeutics with the A? oligomers are also provided. In a particular embodiment, the A? oligomer described herein is comprised of A?42 peptide.
Type:
Grant
Filed:
May 24, 2011
Date of Patent:
January 31, 2017
Assignee:
SYSTEM OF SYSTEMS ANALYTICS, INC.
Inventors:
Roxanne Duan, Jonathan Moll, Alan S. Rudolph
Abstract: Methods of detecting A? oligomers, such as may be present in a biological sample are described. The methods include detection using flow cytometry, detection using synthetic A? oligomers and/or in vitro methods detecting A? oligomers associated with cells.
Type:
Application
Filed:
September 4, 2015
Publication date:
June 16, 2016
Applicant:
SYSTEM OF SYSTEMS ANALYTICS, INC.
Inventors:
Richard O. Cliff, Robert W. Flower, Evgenia G. Matveeva